Medicinal Genomics Hires Sherman Hom as New Director of Regulatory Affairs

According to a press release published last week, Medicinal Genomics has hired Sherman Hom, Ph.D. to be their first director of regulatory affairs. Dr. Hom is coming from a position at New Jersey’s Division of Public Health and Environmental Laboratories (PHEL) where he was the leading [...]

By |22 May 2021|Categories: Regulatory|Comments Off on Medicinal Genomics Hires Sherman Hom as New Director of Regulatory Affairs

Defining Hemp: Classifications, Policies & Markets, Part 2

In Part 1 of this series we answered the question: What is “hemp”; and addressed some of the consequences of defining “hemp” as a thing. In Part 2, I will explore this topic in more detail and provide some commonsense definitions for several traditional hemp products [...]

By |22 May 2021|Categories: Regulatory|Comments Off on
Defining Hemp: Classifications, Policies & Markets, Part 2

Support Grows for Federal Cannabis Legislation with the SAFE and CLAIM Acts

Things are about to change for cannabis and cannabis-related businesses, as landmark legislation to reform federal cannabis banking and insurance laws is just around the corner with the SAFE and CLAIM Acts now making their way through Congress. The Secure and Fair Enforcement (SAFE) Banking Act, [...]

By |22 May 2021|Categories: Regulatory|Comments Off on Support Grows for Federal Cannabis Legislation with the SAFE and CLAIM Acts

Flower-Side Chats Part 4: A Q&A with Adrian Sedlin, CEO & Founder of Canndescent

Flower continues to be the dominant product category in US cannabis sales. In this “Flower-Side Chats” series of articles Green interviews integrated cannabis companies and flower brands that are bringing unique business models to the industry. Particular attention is focused on how these businesses navigate a [...]

By |22 May 2021|Categories: Regulatory|Comments Off on
Flower-Side Chats Part 4: A Q&A with Adrian Sedlin, CEO & Founder of Canndescent